Vaccine Nationalism Among the Public: A Cross-country Experimental Evidence of Own-country Bias Towards COVID-19 Vaccination

Overview

Journal Soc Sci Med

Date 2022 Aug 22

PMID 35994879

Authors

Joan Barcelo

Greg Chih-Hsin Sheen

Hans H Tung

Wen-Chin Wu

Affiliations

Soon will be listed here.

Abstract

What types of vaccines are citizens most likely to accept? We argue that citizens' identification with their nation may lead them to prefer vaccines developed and produced within their national borders, to the exclusion and/or detriment of vaccines from other nations. We administered a conjoint experiment requesting 15,000 adult citizens across 14 individual countries from around the world to assess 450,000 profiles of vaccines that randomly varied on seven attributes. Beyond vaccine fundamentals such as efficacy rate, number of doses, and duration of the protection, we find that citizens systematically favor vaccines developed and produced in their own country of residence. The extent of preference in favor of vaccines developed and produced within the national borders is particularly large among citizens who identify more strongly with their nation, suggesting nationalism plays a role in explaining the bias in favor of vaccines developed and produced locally. This public opinion bias on vaccine preferences has significant theoretical and practical implications.

Citing Articles

Assessing vaccinated persons' intention to take the COVID-19 boosters using a combined theoretical framework: an online survey in Egypt.

El Tantawi M, Elwan A, Hassan R, Mohamed N, Elsheikh E, Hassan H Sci Rep. 2024; 14(1):22795.

PMID: 39353979 PMC: 11445433. DOI: 10.1038/s41598-024-72093-9.

Heritage and hesitancy: how preference for traditional Chinese medicine influences vaccine attitudes.

Lan Y, Jin L Front Public Health. 2024; 12:1355720.

PMID: 38566787 PMC: 10985209. DOI: 10.3389/fpubh.2024.1355720.

Association of National Identity and Trust in Government with COVID-19 Vaccination and Brand Choice in Taiwan.

Kuo C, Yu R J Community Health. 2024; 49(6):967-976.

PMID: 38522040 DOI: 10.1007/s10900-024-01347-4.

Infographics on risks associated with COVID-19 and the willingness to get the AstraZeneca vaccine: two randomized online experiments.

Felgendreff L, Siegers R, Otten L, Betsch C BMC Public Health. 2024; 24(1):529.

PMID: 38378506 PMC: 10880230. DOI: 10.1186/s12889-024-18057-0.

Assessing How Risk Communication Surveillance Prompts COVID-19 Vaccine Acceptance Among Internet Users by Applying the Situational Theory of Problem Solving: Cross-Sectional Study.

Jin Q, Raza S, Yousaf M, Zaman U, Ogadimma E, Shah A JMIR Form Res. 2023; 7:e43628.

PMID: 37315198 PMC: 10373922. DOI: 10.2196/43628.

References

Chou W, Budenz A . Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence. Health Commun. 2020; 35(14):1718-1722. DOI: 10.1080/10410236.2020.1838096. View

Solis Arce J, Warren S, Meriggi N, Scacco A, McMurry N, Voors M . COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021; 27(8):1385-1394. PMC: 8363502. DOI: 10.1038/s41591-021-01454-y. View

Stockli S, Spalti A, Phillips J, Stoeckel F, Barnfield M, Thompson J . Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment. PLoS One. 2022; 17(5):e0266003. PMC: 9067644. DOI: 10.1371/journal.pone.0266003. View

Biswas N, Mustapha T, Khubchandani J, Price J . The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers. J Community Health. 2021; 46(6):1244-1251. PMC: 8056370. DOI: 10.1007/s10900-021-00984-3. View

Duch R, Roope L, Violato M, Becerra M, Robinson T, Bonnefon J . Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities. Proc Natl Acad Sci U S A. 2021; 118(38). PMC: 8463843. DOI: 10.1073/pnas.2026382118. View

Murphy J, Vallieres F, Bentall R, Shevlin M, McBride O, Hartman T . Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021; 12(1):29. PMC: 7782692. DOI: 10.1038/s41467-020-20226-9. View

Kreps S, Kriner D . Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment. Vaccine. 2021; 39(24):3250-3258. PMC: 8064867. DOI: 10.1016/j.vaccine.2021.04.044. View

Cheng C, Barcelo J, Hartnett A, Kubinec R, Messerschmidt L . COVID-19 Government Response Event Dataset (CoronaNet v.1.0). Nat Hum Behav. 2020; 4(7):756-768. DOI: 10.1038/s41562-020-0909-7. View

Allcott H, Boxell L, Conway J, Gentzkow M, Thaler M, Yang D . Polarization and public health: Partisan differences in social distancing during the coronavirus pandemic. J Public Econ. 2020; 191:104254. PMC: 7409721. DOI: 10.1016/j.jpubeco.2020.104254. View

10.

Clarke P, Roope L, Loewen P, Bonnefon J, Melegaro A, Friedman J . Public opinion on global rollout of COVID-19 vaccines. Nat Med. 2021; 27(6):935-936. DOI: 10.1038/s41591-021-01322-9. View

11.

Motta M . Can a COVID-19 vaccine live up to Americans' expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions. Soc Sci Med. 2021; 272:113642. PMC: 7832269. DOI: 10.1016/j.socscimed.2020.113642. View

12.

Hainmueller J, Hangartner D, Yamamoto T . Validating vignette and conjoint survey experiments against real-world behavior. Proc Natl Acad Sci U S A. 2015; 112(8):2395-400. PMC: 4345583. DOI: 10.1073/pnas.1416587112. View

13.

Gramacho W, Turgeon M . When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil. Vaccine. 2021; 39(19):2608-2612. PMC: 8023202. DOI: 10.1016/j.vaccine.2021.03.080. View

14.

Lazarus J, Ratzan S, Palayew A, Gostin L, Larson H, Rabin K . A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020; 27(2):225-228. PMC: 7573523. DOI: 10.1038/s41591-020-1124-9. View

15.

Fidler D . Vaccine nationalism's politics. Science. 2020; 369(6505):749. DOI: 10.1126/science.abe2275. View

16.

Leask J, Willaby H, Kaufman J . The big picture in addressing vaccine hesitancy. Hum Vaccin Immunother. 2014; 10(9):2600-2. PMC: 4975059. DOI: 10.4161/hv.29725. View

17.

Arede M, Bravo-Araya M, Bouchard E, Singh Gill G, Plajer V, Shehraj A . Combating Vaccine Hesitancy: Teaching the Next Generation to Navigate Through the Post Truth Era. Front Public Health. 2019; 6:381. PMC: 6339919. DOI: 10.3389/fpubh.2018.00381. View

18.

Kaplan R, Milstein A . Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci U S A. 2021; 118(10). PMC: 7958192. DOI: 10.1073/pnas.2021726118. View

19.

Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View

20.

Lane S, MacDonald N, Marti M, Dumolard L . Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017. Vaccine. 2018; 36(26):3861-3867. PMC: 5999354. DOI: 10.1016/j.vaccine.2018.03.063. View